Korea’s Lunit reported 37.077 billion won ($26.9 million) in consolidated revenue for the first half of 2025, up 113.5 ...

Korean medical AI firm VUNO pulled in 9.3 billion won ($6.7 million) in second-quarter consolidated revenue, up 45 percent ...

Korea’s Daewoong Pharmaceutical and Daewoong Therapeutics said their semaglutide microneedle patch has achieved more than 80 ...

Bluemtec, a pharmaceutical e-commerce company, announced on Wednesday that it has signed a domestic distribution and marketing agreement with Korean Novartis for the lipid disorder treatment Leqvio (i ...

Ahead of the National Assembly debate on the “Tattoo Artist Act,” which would allow non-medical professionals to perform ...

Korea has approved MSD’s Winrevair (sotatercept) for pulmonary arterial hypertension (PAH), marketed by Merck in the U.S. and ...

Recently, new treatment methods for benign prostatic hyperplasia (BPH) have been introduced, attracting significant attention ...

A model capable of predicting the recurrence of gallbladder cancer within one year after surgery using only preoperative ...

The Ministry of Food and Drug Safety (MFDS) has approved Gilead Sciences’ chimeric antigen receptor T-cell (CAR-T) therapy ...

Etomidate, a general anesthetic agent that has been reported to be illegally administered as a substitute for propofol, has ...

Almost half of lung cancer patients in Korea are diagnosed at stage 4. Since the lungs lack sensory nerves, it is difficult to detect symptoms in the early stages of cancer, making regular screenings ...

To prevent the repeated transfer of patients between emergency rooms, experts suggested that responsibilities for emergency care and final treatment should be separated.Currently, if a patient does no ...